Giant Biogene (02367) spent 13.9713 million Hong Kong dollars to repurchase 400,000 shares on December 17th.
Jinzi Biotech (02367) announced that on December 17, 2025, the company spent HKD 13.9713 million to repurchase 400,000 shares at a price of HKD 34.62-35.22 per share.
GIANT BIOGENE (02367) announced on December 17, 2025 that the company will spend HK $13,971,300 to repurchase 400,000 shares, at a repurchase price range of HK $34.62-35.22 per share.
Related Articles

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


